DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $496 | -48.3% | 2 | -50.0% | 0.00% | 0.0% |
Q2 2023 | $960 | -4.8% | 4 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $1,008 | +0.8% | 4 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,000 | -99.9% | 4 | -99.9% | 0.00% | -99.9% |
Q4 2021 | $1,257,000 | +2518.8% | 3,820 | +2302.5% | 1.08% | +2407.0% |
Q3 2021 | $48,000 | +4700.0% | 159 | +7850.0% | 0.04% | +4200.0% |
Q2 2021 | $1,000 | -98.7% | 2 | -99.4% | 0.00% | -98.4% |
Q1 2021 | $76,000 | -94.3% | 338 | -94.3% | 0.06% | -94.1% |
Q4 2020 | $1,325,000 | -19.3% | 5,965 | -21.7% | 1.05% | -15.4% |
Q3 2020 | $1,641,000 | – | 7,620 | +380900.0% | 1.24% | – |
Q2 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
Q3 2019 | $2,922,000 | +4.4% | 20,228 | -38.2% | 1.13% | +68.2% |
Q1 2017 | $2,799,000 | +2.2% | 32,731 | -6.9% | 0.67% | -1.0% |
Q4 2016 | $2,738,000 | +8.7% | 35,170 | +9.5% | 0.68% | +5.4% |
Q3 2016 | $2,519,000 | – | 32,128 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |